A new report from BioCrossroads shows dramatic gains in venture capital funding in Indiana’s life sciences sector. In 2022, 39 companies raised a total of $619 million. This is a 136% increase over 2020’s $262 million and a 65% increase over 2021’s $433 million. Since a comparable number of companies raised capital in those years, the report attributes the gains to an increase in average deal size. Additionally, there was a $124 million funding round for one agtech company, Inari. Had that investment not occurred there still would have been a 14% year-over-year increase.